Agendia announced two partnerships that will bring its genomic testing platforms to more patients.
The Amsterdam-based company has reached a deal with Illumina to co-develop an in vitro diagnostic based on Agendia’s MamaPrint...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?